Your browser doesn't support javascript.
loading
Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.
Schloemer, Nathan J; Abu-Sultaneh, Samer; Hanson, Sheila J; Yan, Ke; Hoffmann, Raymond G; Punzalan, Rowena C; Havens, Peter L.
Afiliação
  • Schloemer NJ; 1Department of Pediatrics, Division of Critical Care, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, WI. 2Department of Pediatrics, Section of Pediatric Critical Care Medicine, Riley Hospital for Children at Indiana University Health and Indiana University School of Medicine, Indianapolis, IN. 3Department of Pediatrics, Division of Quantitative Health Sciences, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, WI. 4Department of Pediatri
Pediatr Crit Care Med ; 15(7): e294-9, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24901803

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enoxaparina / Cuidados Críticos / Tromboembolia Venosa / Fibrinolíticos / Inibidores do Fator Xa Tipo de estudo: Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Crit Care Med Assunto da revista: PEDIATRIA / TERAPIA INTENSIVA Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enoxaparina / Cuidados Críticos / Tromboembolia Venosa / Fibrinolíticos / Inibidores do Fator Xa Tipo de estudo: Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Crit Care Med Assunto da revista: PEDIATRIA / TERAPIA INTENSIVA Ano de publicação: 2014 Tipo de documento: Article